Let's Talk Risk!

Let's Talk Risk!

Home
Podcast
Chat
Business Acumen
QMSR Compliance
Wall of Love
Archive
About
17:10
Case Study: A Warning Letter Exposes Issues in Risk Analysis
Lessons learned from a recent FDA warning letter highlighting systemic issues in risk analysis, design verification and post-market vigilance for a…
 • 
Naveen Agarwal, Ph.D.
11:22
Case Study: A Promising Device Fails in the Market Due to Usability Issues
5 years after acquiring a promising medical device, a major MedTech discontinued marketing following a Class I recall. Here are a few lessons learned…
 • 
Naveen Agarwal, Ph.D.
3
34:53
LTR 102: Collaboration that drives innovation, not delays
Deep insights from a conversation with Ahmet Tezel.
Most Popular
View all
ISO 14971 Fundamentals: Characteristics related to safety
 • Naveen Agarwal, Ph.D.
5
Webinar 10: Tips for medical device software risk analysis
 • Naveen Agarwal, Ph.D.
2
LTR 102: Collaboration that drives innovation, not delays
LTR 82: Tips for Regulatory Success with AI Devices in Radiology
 • Naveen Agarwal, Ph.D.
Webinar 7: How to create a master harms list using standard codes
 • Naveen Agarwal, Ph.D.
1
Case study: Neither a SaMD, nor a SiMD; maybe a SaMDA?
 • Naveen Agarwal, Ph.D.
1

Case studies

See all
17:10
Case Study: A Warning Letter Exposes Issues in Risk Analysis
Lessons learned from a recent FDA warning letter highlighting systemic issues in risk analysis, design verification and post-market vigilance for a…
 • 
Naveen Agarwal, Ph.D.
11:22
Case Study: A Promising Device Fails in the Market Due to Usability Issues
5 years after acquiring a promising medical device, a major MedTech discontinued marketing following a Class I recall. Here are a few lessons learned…
 • 
Naveen Agarwal, Ph.D.
3
Case study: A smart benefit-risk strategy for market entry via the De Novo pathway
Lessons learned from a smart strategy to demonstrate safety and effectiveness of a novel software device through evidence-based benefit-risk…
 • 
Ritam Priya
 and 
Naveen Agarwal, Ph.D.

Webinars

See all
48:31
Webinar 10: Tips for medical device software risk analysis
An overview of key challenges and tips for analyzing the risks of medical device software failures.
 • 
Naveen Agarwal, Ph.D.
2
54:26
Webinar 9: How to set up post-market surveillance
A review of ISO 14971 requirements and practical tips to set up an efficient and effective post-market safety surveillance process for your medical…
 • 
Naveen Agarwal, Ph.D.
56:41
Webinar 8: Case study discussion and Q&A
Watch now | A case study about a warning letter for miscalculating risk and a general Q&A session about risk management.
 • 
Naveen Agarwal, Ph.D.

Quick tips

See all

Risk management fundamentals

See all

Medtech news

See all

AMA on Risk Management

See all

LTR weekly digests

See all
Let's Talk Risk!
Let's Talk Risk!
Building competence through content, community and conversations.
Recommendations
The FDA Group's Insider Newsletter
The FDA Group's Insider Newsletter
The FDA Group
On the Edge of Resilience
On the Edge of Resilience
Marco
What the FDA?
What the FDA?
Steve Silverman
The Other Consultants: MedTech Quality & Regulatory Insights
The Other Consultants: MedTech Quality & Regulatory Insights
Adam Isaacs Rae

Let's Talk Risk!

AboutArchiveRecommendationsSitemap
© 2025 Naveen Agarwal, Ph.D.
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture